Population-based study of capsular warning syndrome and prognosis after early recurrent TIA
- PMID: 22972645
- PMCID: PMC3448742
- DOI: 10.1212/WNL.0b013e31826c1af8
Population-based study of capsular warning syndrome and prognosis after early recurrent TIA
Abstract
Objective: Many guidelines recommend emergency assessment for patients with ≥2 TIAs within 7 days, perhaps in recognition of the capsular warning syndrome. However, it is unclear whether all patients with multiple TIAs are at high early risk of stroke and whether treatable underlying pathologies are more prevalent in this group.
Methods: We studied clinical characteristics, Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification, and risk of stroke in 1,000 consecutive patients with incident and recurrent TIAs in a prospective, population-based study (Oxford Vascular Study).
Results: Of 1,000 patients with TIAs, 170 had a further TIA within 7 days (105 within 24 hours). Multiple TIAs were not associated with carotid stenosis or atrial fibrillation, and much of the 10.6 (95% confidence interval [CI] 6.5-15.9) risk of stroke during the 7 days after the first TIA was due to patients with small-vessel disease (SVD) etiology (10 of 24 vs 8 of 146, odds ratio [OR] = 12.3, 95% CI 3.7-41.9, p < 0.0001), particularly those with motor weakness (i.e., capsular warning syndrome) compared with hemisensory events (9 of 15 [60%], 95% CI 35.3-84.7 vs 1 of 9 [11.1%], 95% CI 0-31.7, p = 0.03). The 7-day risk of stroke after a recurrent TIA was similar to the risk after a single TIA in patients with non-SVD TIA (8 of 146 [5.5%] vs 76 of 830 [9.2%], OR = 0.58, 95% CI 0.25-1.3, p = 0.20). Of the 9 patients with stroke after a capsular warning syndrome, all had the recurrent TIA within 24 hours after the first TIA, and the subsequent stroke occurred within 72 hours of the second TIA in 8. The ABCD2 scores of all preceding TIAs were ≥4 in all 9 patients with capsular warning syndrome before stroke.
Conclusions: Capsular warning syndrome is rare (1.5% of TIA presentations) but has a poor prognosis (7-day stroke risk of 60%). Otherwise, recurrent TIA within 7 days is not associated with a greater stroke risk than that after a single TIA.
Figures
Similar articles
-
Diagnosis of non-consensus transient ischaemic attacks with focal, negative, and non-progressive symptoms: population-based validation by investigation and prognosis.Lancet. 2021 Mar 6;397(10277):902-912. doi: 10.1016/S0140-6736(20)31961-9. Lancet. 2021. PMID: 33676629 Free PMC article.
-
Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort.Cerebrovasc Dis. 2023;52(2):218-225. doi: 10.1159/000525954. Epub 2022 Sep 9. Cerebrovasc Dis. 2023. PMID: 36088905
-
Prospective observational cohort study of early recurrent TIA: Features, frequency, and outcome.Neurology. 2020 Sep 22;95(12):e1733-e1744. doi: 10.1212/WNL.0000000000010317. Epub 2020 Jul 29. Neurology. 2020. PMID: 32727840
-
Stroke warning syndrome.Clin Neurol Neurosurg. 2022 Feb;213:107120. doi: 10.1016/j.clineuro.2022.107120. Epub 2022 Jan 10. Clin Neurol Neurosurg. 2022. PMID: 35074686 Review.
-
An assessment of the cost-effectiveness of magnetic resonance, including diffusion-weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluation.Health Technol Assess. 2014 Apr;18(27):1-368, v-vi. doi: 10.3310/hta18270. Health Technol Assess. 2014. PMID: 24791949 Free PMC article. Review.
Cited by
-
Capsular warning syndrome-a case of atrial fibrillation and corona radiata infarct.Int J Emerg Med. 2023 Sep 26;16(1):62. doi: 10.1186/s12245-023-00541-w. Int J Emerg Med. 2023. PMID: 37752459 Free PMC article.
-
Capsular warning syndrome and its clinical awareness and therapeutic approach: two case reports and a systematic review of the literature.Front Neurol. 2023 May 16;14:1177660. doi: 10.3389/fneur.2023.1177660. eCollection 2023. Front Neurol. 2023. PMID: 37260605 Free PMC article.
-
Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS).Front Neurosci. 2022 Nov 16;16:1026127. doi: 10.3389/fnins.2022.1026127. eCollection 2022. Front Neurosci. 2022. PMID: 36466171 Free PMC article.
-
'Crescendo transient ischemic attack'-an uncommon presentation of a very common disease: a case report on capsular warning syndrome.Oxf Med Case Reports. 2022 Jan 24;2022(1):omab129. doi: 10.1093/omcr/omab129. eCollection 2022 Jan. Oxf Med Case Reports. 2022. PMID: 35083048 Free PMC article.
-
Attack Interval Is the Key to the Likely Pathogenesis of Multiple Transient Ischemic Attacks.Cerebrovasc Dis Extra. 2021;11(3):92-98. doi: 10.1159/000519105. Epub 2021 Sep 30. Cerebrovasc Dis Extra. 2021. PMID: 34592739 Free PMC article.
References
-
- Giles MF, Rothwell PM. Substantial underestimation of the need for outpatient services for TIA and minor stroke. Age Ageing 2007;36:676–680 - PubMed
-
- Kleindorfer D, Panagos P, Pancioli A, et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005;36:720–723 - PubMed
-
- Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology 2004;62:2015–2020 - PubMed
-
- Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901–2906 - PubMed
-
- Lisabeth LD, Ireland JK, Risser JM, et al. Stroke risk after transient ischemic attack in a population-based setting. Stroke 2004;35:1842–1846 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical